Harmony Biosciences chief commercial officer sells shares worth $1.15m By Investing.com
Following these transactions, Dierks no longer holds shares in the company. Harmony (JO:) Biosciences, which maintains an excellent financial health score according to InvestingPro data, holds more cash than debt on its balance sheet and demonstrates strong liquidity with a current ratio of 3.24. The pharmaceutical company continues to focus on developing and commercializing innovative […]
Harmony Biosciences chief commercial officer sells shares worth $1.15m By Investing.com Read More »